Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Impact of small node size on clinical interpretation of F18 FDG PET CT for primary head and neck SCC malignancy. Bad things can come in small packages.

Louise Emmett, Jonathan Lee, Reuben Tang and Bao Ho
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 217;
Louise Emmett
2390 Victoria St Garvan Institute of medical research Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Lee
1Darlinghurst Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reuben Tang
3390 Victoria St St Vincent's Hospital Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bao Ho
4390 Victoria St St Vincent's Hospital Sydney Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

217

Objectives: Evaluation of cervical nodal metastases is vital for pre-treatment staging of patients with head and neck squamous cell carcinoma (HNSCC). Integrated PET / CT has been well validated for evaluation of primary, nodal and distant disease in HNSCC patients. However, assessment of small volume nodes remains a dilemma. Few studies have evaluated the significance of quantitative assessment with SUV max for diagnosis of nodal metastases within the sub-centimetre nodal group. The aim of this study was to assess diagnostic accuracy of FDG-PET / CT in evaluation of cervical nodal metastases based on nodal size and by HPV status.

Methods: 38 patients with primary head and neck SCC were prospectively recruited over a 2 year period from 2014 to 2015. All patients underwent resection of the primary tumour and cervical node dissection following FDG-PET / CT evaluation at our institution. Surgical nodal dissection was in blocks according to node station. Neck dissection was unilateral in 8/38, and bilateral in 30/38 patients. F18 FDG-PET / CT images were acquired 60 minutes after injection of F18 FDG. The PET and CT images were read clinically by experienced readers blinded to the surgical results, and assessment of SUV max was undertaken in all visible nodes, to derive ROC curves for varying nodal sizes.

Results: 38 patients had 67 neck sides dissected (32 bilateral, 6 bilateral), involving 353 nodal levels and a total of 2700 lymph nodes (mean 40.3 lymph nodes per neck side). Histopathological analysis revealed lymph node metastases in 116 of the 2701 dissected lymph nodes (4.3%). Mean size of pathologically involved nodes was 11mm, of whom 64% were sub-centimeter. On nodal based analysis, overall clinical sensitivity, specificity and diagnostic odds ratio were 51.7%, 98.7% and 82.8% for PET / CT. Using cervical node levels based analysis, the sensitivity, specificity was 75% and 94%. Clinical sensitivity, specificity and diagnostic odds ratio of PET / CT for sub-centimeter nodes were 30.7%, 99.2% and 57.6 compared to 90.2%, 84.8% and 51.5 for supra-centimeter nodes. All nodes with SUV max >5.0 were all confirmed to be metastatic on histopathology. Using ROC analysis for sub-centimeter nodes, the optimal SUV max cutoff was determined at 2.3, yielding a sensitivity and specificity of 73.7% and 94.4%. By contrast, in 蠅1cm nodes, a higher SUV max, 4.9 achieved similar sensitivity and specificity of 73.2% and 99.1% respectively.

Conclusion: Sub-centimeter lymph nodes are the most prevalent involved node size in HNSCC. SUV max cutoffs of 2.3 demonstrated a superior sensitivity to clinical reading by experts, suggesting that we need to recalibrate interpretation of quantitative FDG findings in small nodes in patients with known malignancy, to improve diagnostic accuracy. Research Support:

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of small node size on clinical interpretation of F18 FDG PET CT for primary head and neck SCC malignancy. Bad things can come in small packages.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Impact of small node size on clinical interpretation of F18 FDG PET CT for primary head and neck SCC malignancy. Bad things can come in small packages.
Louise Emmett, Jonathan Lee, Reuben Tang, Bao Ho
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 217;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of small node size on clinical interpretation of F18 FDG PET CT for primary head and neck SCC malignancy. Bad things can come in small packages.
Louise Emmett, Jonathan Lee, Reuben Tang, Bao Ho
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 217;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Head & Neck I

  • Identification of recurrence sites using initial PET/CT in head and neck cancer treated by radio-chemotherapy.
  • The added value of 18F-FDG-PET-CT compared with conventional Imaging modalities in paediatric nasopharyngeal carcinoma
  • Prognostic prediction of early oral squamous cell carcinoma using FDG-PET/CT.
Show more Head & Neck I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire